All In Biotech

Free tool

FAERS Monitor: Piqray

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 212526 or its brand name (Piqray, Alpelisib). Reports on generic versions are filed under their own applications.

Reports

8,387

Serious

4,816

57% of reports

Hospitalization

1,655

Death reported

1,229

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • hyperglycaemia1,498
  • rash1,384
  • diarrhoea1,320
  • blood glucose increased1,120
  • death900
  • nausea847
  • fatigue839
  • decreased appetite541
  • malignant neoplasm progression519
  • weight decreased519
  • vomiting484
  • drug ineffective376
  • asthenia345
  • stomatitis331
  • pruritus281

Reports by year received

View as table
YearReports
20151
20161
20176
20184
2019802
20201,738
20211,761
20221,704
20231,386
2024504
2025266
2026214

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,772 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hyperglycaemiaSignal1,498107.5102.5151,684
blood glucose increasedSignal1,12015.014.214,655
stomatitisSignal33113.812.43,892
malignant neoplasm progressionSignal51912.811.75,617
rashSignal1,3848.07.68,600
decreased appetiteSignal5415.95.42,191
diarrhoeaSignal1,3205.14.94,523
weight decreasedSignal5194.74.31,510
fatigueSignal8392.72.5933
nauseaSignal8472.72.5928
deathSignal9002.62.5939
vomitingSignal4842.62.4478
astheniaSignal3452.32.1257
pruritus2811.81.6108
drug ineffective3760.70.645

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.